CHASE INVESTMENT COUNSEL CORP – Vertex Pharmaceuticals Incorporated Transaction History
CHASE INVESTMENT COUNSEL CORP portfolio value:
$3.31M
portfolio value
CHASE INVESTMENT COUNSEL CORP quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +36.11% | 3.03K shares | 944K | $289.54 | 11.43K |
| Q2 2022 | share | Increase | 0.00% | 8.40K shares | 2.36M | $281.79 | 8.40K |
| Q4 2020 | share | Decrease | -100.00% | -11.37K shares | -3.09M | $236.34 | 0 |
| Q3 2020 | share | Decrease | -14.22% | -1.88K shares | -754K | $272.12 | 11.37K |
| Q2 2020 | share | Decrease | -18.56% | -3.02K shares | -25K | $290.31 | 13.26K |
| Q1 2020 | share | Increase | 0.00% | 16.28K shares | 3.87M | $237.95 | 16.28K |